Global Companion Diagnostics for Oncology Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Companion Diagnostics for Oncology market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Companion Diagnostics for Oncology market are covered in Chapter 9:
Abbott
Invivoscribe, Inc.
QIAGEN N.V.
Agilent Technologies, Inc.
bioMerieux SA
F. Hoffmann-La Roche Ltd.
Thermo Fisher Scientific, Inc.
ARUP Laboratories
Myriad Genetics, Inc.
Illumina, Inc.
In Chapter 5 and Chapter 7.3, based on types, the Companion Diagnostics for Oncology market from 2017 to 2027 is primarily split into:
Product
Service
In Chapter 6 and Chapter 7.4, based on applications, the Companion Diagnostics for Oncology market from 2017 to 2027 covers:
Hospital
Pathology/Diagnostic Laboratory
Academic Medical Center
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Companion Diagnostics for Oncology market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Companion Diagnostics for Oncology Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Companion Diagnostics for Oncology market are covered in Chapter 9:
Abbott
Invivoscribe, Inc.
QIAGEN N.V.
Agilent Technologies, Inc.
bioMerieux SA
F. Hoffmann-La Roche Ltd.
Thermo Fisher Scientific, Inc.
ARUP Laboratories
Myriad Genetics, Inc.
Illumina, Inc.
In Chapter 5 and Chapter 7.3, based on types, the Companion Diagnostics for Oncology market from 2017 to 2027 is primarily split into:
Product
Service
In Chapter 6 and Chapter 7.4, based on applications, the Companion Diagnostics for Oncology market from 2017 to 2027 covers:
Hospital
Pathology/Diagnostic Laboratory
Academic Medical Center
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Companion Diagnostics for Oncology market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Companion Diagnostics for Oncology Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 COMPANION DIAGNOSTICS FOR ONCOLOGY MARKET OVERVIEW
1.1 Product Overview and Scope of Companion Diagnostics for Oncology Market
1.2 Companion Diagnostics for Oncology Market Segment by Type
1.2.1 Global Companion Diagnostics for Oncology Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Companion Diagnostics for Oncology Market Segment by Application
1.3.1 Companion Diagnostics for Oncology Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Companion Diagnostics for Oncology Market, Region Wise (2017-2027)
1.4.1 Global Companion Diagnostics for Oncology Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Companion Diagnostics for Oncology Market Status and Prospect (2017-2027)
1.4.3 Europe Companion Diagnostics for Oncology Market Status and Prospect (2017-2027)
1.4.4 China Companion Diagnostics for Oncology Market Status and Prospect (2017-2027)
1.4.5 Japan Companion Diagnostics for Oncology Market Status and Prospect (2017-2027)
1.4.6 India Companion Diagnostics for Oncology Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Companion Diagnostics for Oncology Market Status and Prospect (2017-2027)
1.4.8 Latin America Companion Diagnostics for Oncology Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Companion Diagnostics for Oncology Market Status and Prospect (2017-2027)
1.5 Global Market Size of Companion Diagnostics for Oncology (2017-2027)
1.5.1 Global Companion Diagnostics for Oncology Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Companion Diagnostics for Oncology Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Companion Diagnostics for Oncology Market
2 INDUSTRY OUTLOOK
2.1 Companion Diagnostics for Oncology Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Companion Diagnostics for Oncology Market Drivers Analysis
2.4 Companion Diagnostics for Oncology Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Companion Diagnostics for Oncology Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Companion Diagnostics for Oncology Industry Development
3 GLOBAL COMPANION DIAGNOSTICS FOR ONCOLOGY MARKET LANDSCAPE BY PLAYER
3.1 Global Companion Diagnostics for Oncology Sales Volume and Share by Player (2017-2022)
3.2 Global Companion Diagnostics for Oncology Revenue and Market Share by Player (2017-2022)
3.3 Global Companion Diagnostics for Oncology Average Price by Player (2017-2022)
3.4 Global Companion Diagnostics for Oncology Gross Margin by Player (2017-2022)
3.5 Companion Diagnostics for Oncology Market Competitive Situation and Trends
3.5.1 Companion Diagnostics for Oncology Market Concentration Rate
3.5.2 Companion Diagnostics for Oncology Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL COMPANION DIAGNOSTICS FOR ONCOLOGY SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Companion Diagnostics for Oncology Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Companion Diagnostics for Oncology Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Companion Diagnostics for Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Companion Diagnostics for Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Companion Diagnostics for Oncology Market Under COVID-19
4.5 Europe Companion Diagnostics for Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Companion Diagnostics for Oncology Market Under COVID-19
4.6 China Companion Diagnostics for Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Companion Diagnostics for Oncology Market Under COVID-19
4.7 Japan Companion Diagnostics for Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Companion Diagnostics for Oncology Market Under COVID-19
4.8 India Companion Diagnostics for Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Companion Diagnostics for Oncology Market Under COVID-19
4.9 Southeast Asia Companion Diagnostics for Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Companion Diagnostics for Oncology Market Under COVID-19
4.10 Latin America Companion Diagnostics for Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Companion Diagnostics for Oncology Market Under COVID-19
4.11 Middle East and Africa Companion Diagnostics for Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Companion Diagnostics for Oncology Market Under COVID-19
5 GLOBAL COMPANION DIAGNOSTICS FOR ONCOLOGY SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Companion Diagnostics for Oncology Sales Volume and Market Share by Type (2017-2022)
5.2 Global Companion Diagnostics for Oncology Revenue and Market Share by Type (2017-2022)
5.3 Global Companion Diagnostics for Oncology Price by Type (2017-2022)
5.4 Global Companion Diagnostics for Oncology Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Companion Diagnostics for Oncology Sales Volume, Revenue and Growth Rate of Product (2017-2022)
5.4.2 Global Companion Diagnostics for Oncology Sales Volume, Revenue and Growth Rate of Service (2017-2022)
6 GLOBAL COMPANION DIAGNOSTICS FOR ONCOLOGY MARKET ANALYSIS BY APPLICATION
6.1 Global Companion Diagnostics for Oncology Consumption and Market Share by Application (2017-2022)
6.2 Global Companion Diagnostics for Oncology Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Companion Diagnostics for Oncology Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Companion Diagnostics for Oncology Consumption and Growth Rate of Hospital (2017-2022)
6.3.2 Global Companion Diagnostics for Oncology Consumption and Growth Rate of Pathology/Diagnostic Laboratory (2017-2022)
6.3.3 Global Companion Diagnostics for Oncology Consumption and Growth Rate of Academic Medical Center (2017-2022)
7 GLOBAL COMPANION DIAGNOSTICS FOR ONCOLOGY MARKET FORECAST (2022-2027)
7.1 Global Companion Diagnostics for Oncology Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Companion Diagnostics for Oncology Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Companion Diagnostics for Oncology Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Companion Diagnostics for Oncology Price and Trend Forecast (2022-2027)
7.2 Global Companion Diagnostics for Oncology Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Companion Diagnostics for Oncology Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Companion Diagnostics for Oncology Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Companion Diagnostics for Oncology Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Companion Diagnostics for Oncology Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Companion Diagnostics for Oncology Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Companion Diagnostics for Oncology Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Companion Diagnostics for Oncology Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Companion Diagnostics for Oncology Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Companion Diagnostics for Oncology Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Companion Diagnostics for Oncology Revenue and Growth Rate of Product (2022-2027)
7.3.2 Global Companion Diagnostics for Oncology Revenue and Growth Rate of Service (2022-2027)
7.4 Global Companion Diagnostics for Oncology Consumption Forecast by Application (2022-2027)
7.4.1 Global Companion Diagnostics for Oncology Consumption Value and Growth Rate of Hospital(2022-2027)
7.4.2 Global Companion Diagnostics for Oncology Consumption Value and Growth Rate of Pathology/Diagnostic Laboratory(2022-2027)
7.4.3 Global Companion Diagnostics for Oncology Consumption Value and Growth Rate of Academic Medical Center(2022-2027)
7.5 Companion Diagnostics for Oncology Market Forecast Under COVID-19
8 COMPANION DIAGNOSTICS FOR ONCOLOGY MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Companion Diagnostics for Oncology Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Companion Diagnostics for Oncology Analysis
8.6 Major Downstream Buyers of Companion Diagnostics for Oncology Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Companion Diagnostics for Oncology Industry
9 PLAYERS PROFILES
9.1 Abbott
9.1.1 Abbott Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Companion Diagnostics for Oncology Product Profiles, Application and Specification
9.1.3 Abbott Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Invivoscribe, Inc.
9.2.1 Invivoscribe, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Companion Diagnostics for Oncology Product Profiles, Application and Specification
9.2.3 Invivoscribe, Inc. Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 QIAGEN N.V.
9.3.1 QIAGEN N.V. Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Companion Diagnostics for Oncology Product Profiles, Application and Specification
9.3.3 QIAGEN N.V. Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Agilent Technologies, Inc.
9.4.1 Agilent Technologies, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Companion Diagnostics for Oncology Product Profiles, Application and Specification
9.4.3 Agilent Technologies, Inc. Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 bioMerieux SA
9.5.1 bioMerieux SA Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Companion Diagnostics for Oncology Product Profiles, Application and Specification
9.5.3 bioMerieux SA Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 F. Hoffmann-La Roche Ltd.
9.6.1 F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Companion Diagnostics for Oncology Product Profiles, Application and Specification
9.6.3 F. Hoffmann-La Roche Ltd. Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Thermo Fisher Scientific, Inc.
9.7.1 Thermo Fisher Scientific, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Companion Diagnostics for Oncology Product Profiles, Application and Specification
9.7.3 Thermo Fisher Scientific, Inc. Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 ARUP Laboratories
9.8.1 ARUP Laboratories Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Companion Diagnostics for Oncology Product Profiles, Application and Specification
9.8.3 ARUP Laboratories Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Myriad Genetics, Inc.
9.9.1 Myriad Genetics, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Companion Diagnostics for Oncology Product Profiles, Application and Specification
9.9.3 Myriad Genetics, Inc. Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Illumina, Inc.
9.10.1 Illumina, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Companion Diagnostics for Oncology Product Profiles, Application and Specification
9.10.3 Illumina, Inc. Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
1.1 Product Overview and Scope of Companion Diagnostics for Oncology Market
1.2 Companion Diagnostics for Oncology Market Segment by Type
1.2.1 Global Companion Diagnostics for Oncology Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Companion Diagnostics for Oncology Market Segment by Application
1.3.1 Companion Diagnostics for Oncology Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Companion Diagnostics for Oncology Market, Region Wise (2017-2027)
1.4.1 Global Companion Diagnostics for Oncology Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Companion Diagnostics for Oncology Market Status and Prospect (2017-2027)
1.4.3 Europe Companion Diagnostics for Oncology Market Status and Prospect (2017-2027)
1.4.4 China Companion Diagnostics for Oncology Market Status and Prospect (2017-2027)
1.4.5 Japan Companion Diagnostics for Oncology Market Status and Prospect (2017-2027)
1.4.6 India Companion Diagnostics for Oncology Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Companion Diagnostics for Oncology Market Status and Prospect (2017-2027)
1.4.8 Latin America Companion Diagnostics for Oncology Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Companion Diagnostics for Oncology Market Status and Prospect (2017-2027)
1.5 Global Market Size of Companion Diagnostics for Oncology (2017-2027)
1.5.1 Global Companion Diagnostics for Oncology Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Companion Diagnostics for Oncology Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Companion Diagnostics for Oncology Market
2 INDUSTRY OUTLOOK
2.1 Companion Diagnostics for Oncology Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Companion Diagnostics for Oncology Market Drivers Analysis
2.4 Companion Diagnostics for Oncology Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Companion Diagnostics for Oncology Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Companion Diagnostics for Oncology Industry Development
3 GLOBAL COMPANION DIAGNOSTICS FOR ONCOLOGY MARKET LANDSCAPE BY PLAYER
3.1 Global Companion Diagnostics for Oncology Sales Volume and Share by Player (2017-2022)
3.2 Global Companion Diagnostics for Oncology Revenue and Market Share by Player (2017-2022)
3.3 Global Companion Diagnostics for Oncology Average Price by Player (2017-2022)
3.4 Global Companion Diagnostics for Oncology Gross Margin by Player (2017-2022)
3.5 Companion Diagnostics for Oncology Market Competitive Situation and Trends
3.5.1 Companion Diagnostics for Oncology Market Concentration Rate
3.5.2 Companion Diagnostics for Oncology Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL COMPANION DIAGNOSTICS FOR ONCOLOGY SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Companion Diagnostics for Oncology Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Companion Diagnostics for Oncology Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Companion Diagnostics for Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Companion Diagnostics for Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Companion Diagnostics for Oncology Market Under COVID-19
4.5 Europe Companion Diagnostics for Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Companion Diagnostics for Oncology Market Under COVID-19
4.6 China Companion Diagnostics for Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Companion Diagnostics for Oncology Market Under COVID-19
4.7 Japan Companion Diagnostics for Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Companion Diagnostics for Oncology Market Under COVID-19
4.8 India Companion Diagnostics for Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Companion Diagnostics for Oncology Market Under COVID-19
4.9 Southeast Asia Companion Diagnostics for Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Companion Diagnostics for Oncology Market Under COVID-19
4.10 Latin America Companion Diagnostics for Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Companion Diagnostics for Oncology Market Under COVID-19
4.11 Middle East and Africa Companion Diagnostics for Oncology Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Companion Diagnostics for Oncology Market Under COVID-19
5 GLOBAL COMPANION DIAGNOSTICS FOR ONCOLOGY SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Companion Diagnostics for Oncology Sales Volume and Market Share by Type (2017-2022)
5.2 Global Companion Diagnostics for Oncology Revenue and Market Share by Type (2017-2022)
5.3 Global Companion Diagnostics for Oncology Price by Type (2017-2022)
5.4 Global Companion Diagnostics for Oncology Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Companion Diagnostics for Oncology Sales Volume, Revenue and Growth Rate of Product (2017-2022)
5.4.2 Global Companion Diagnostics for Oncology Sales Volume, Revenue and Growth Rate of Service (2017-2022)
6 GLOBAL COMPANION DIAGNOSTICS FOR ONCOLOGY MARKET ANALYSIS BY APPLICATION
6.1 Global Companion Diagnostics for Oncology Consumption and Market Share by Application (2017-2022)
6.2 Global Companion Diagnostics for Oncology Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Companion Diagnostics for Oncology Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Companion Diagnostics for Oncology Consumption and Growth Rate of Hospital (2017-2022)
6.3.2 Global Companion Diagnostics for Oncology Consumption and Growth Rate of Pathology/Diagnostic Laboratory (2017-2022)
6.3.3 Global Companion Diagnostics for Oncology Consumption and Growth Rate of Academic Medical Center (2017-2022)
7 GLOBAL COMPANION DIAGNOSTICS FOR ONCOLOGY MARKET FORECAST (2022-2027)
7.1 Global Companion Diagnostics for Oncology Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Companion Diagnostics for Oncology Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Companion Diagnostics for Oncology Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Companion Diagnostics for Oncology Price and Trend Forecast (2022-2027)
7.2 Global Companion Diagnostics for Oncology Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Companion Diagnostics for Oncology Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Companion Diagnostics for Oncology Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Companion Diagnostics for Oncology Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Companion Diagnostics for Oncology Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Companion Diagnostics for Oncology Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Companion Diagnostics for Oncology Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Companion Diagnostics for Oncology Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Companion Diagnostics for Oncology Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Companion Diagnostics for Oncology Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Companion Diagnostics for Oncology Revenue and Growth Rate of Product (2022-2027)
7.3.2 Global Companion Diagnostics for Oncology Revenue and Growth Rate of Service (2022-2027)
7.4 Global Companion Diagnostics for Oncology Consumption Forecast by Application (2022-2027)
7.4.1 Global Companion Diagnostics for Oncology Consumption Value and Growth Rate of Hospital(2022-2027)
7.4.2 Global Companion Diagnostics for Oncology Consumption Value and Growth Rate of Pathology/Diagnostic Laboratory(2022-2027)
7.4.3 Global Companion Diagnostics for Oncology Consumption Value and Growth Rate of Academic Medical Center(2022-2027)
7.5 Companion Diagnostics for Oncology Market Forecast Under COVID-19
8 COMPANION DIAGNOSTICS FOR ONCOLOGY MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Companion Diagnostics for Oncology Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Companion Diagnostics for Oncology Analysis
8.6 Major Downstream Buyers of Companion Diagnostics for Oncology Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Companion Diagnostics for Oncology Industry
9 PLAYERS PROFILES
9.1 Abbott
9.1.1 Abbott Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Companion Diagnostics for Oncology Product Profiles, Application and Specification
9.1.3 Abbott Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Invivoscribe, Inc.
9.2.1 Invivoscribe, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Companion Diagnostics for Oncology Product Profiles, Application and Specification
9.2.3 Invivoscribe, Inc. Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 QIAGEN N.V.
9.3.1 QIAGEN N.V. Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Companion Diagnostics for Oncology Product Profiles, Application and Specification
9.3.3 QIAGEN N.V. Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Agilent Technologies, Inc.
9.4.1 Agilent Technologies, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Companion Diagnostics for Oncology Product Profiles, Application and Specification
9.4.3 Agilent Technologies, Inc. Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 bioMerieux SA
9.5.1 bioMerieux SA Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Companion Diagnostics for Oncology Product Profiles, Application and Specification
9.5.3 bioMerieux SA Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 F. Hoffmann-La Roche Ltd.
9.6.1 F. Hoffmann-La Roche Ltd. Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Companion Diagnostics for Oncology Product Profiles, Application and Specification
9.6.3 F. Hoffmann-La Roche Ltd. Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Thermo Fisher Scientific, Inc.
9.7.1 Thermo Fisher Scientific, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Companion Diagnostics for Oncology Product Profiles, Application and Specification
9.7.3 Thermo Fisher Scientific, Inc. Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 ARUP Laboratories
9.8.1 ARUP Laboratories Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Companion Diagnostics for Oncology Product Profiles, Application and Specification
9.8.3 ARUP Laboratories Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 Myriad Genetics, Inc.
9.9.1 Myriad Genetics, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Companion Diagnostics for Oncology Product Profiles, Application and Specification
9.9.3 Myriad Genetics, Inc. Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Illumina, Inc.
9.10.1 Illumina, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Companion Diagnostics for Oncology Product Profiles, Application and Specification
9.10.3 Illumina, Inc. Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Companion Diagnostics for Oncology Product Picture
Table Global Companion Diagnostics for Oncology Market Sales Volume and CAGR (%) Comparison by Type
Table Companion Diagnostics for Oncology Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Companion Diagnostics for Oncology Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Companion Diagnostics for Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Companion Diagnostics for Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Companion Diagnostics for Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Companion Diagnostics for Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Companion Diagnostics for Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Companion Diagnostics for Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Companion Diagnostics for Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Companion Diagnostics for Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Companion Diagnostics for Oncology Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Companion Diagnostics for Oncology Industry Development
Table Global Companion Diagnostics for Oncology Sales Volume by Player (2017-2022)
Table Global Companion Diagnostics for Oncology Sales Volume Share by Player (2017-2022)
Figure Global Companion Diagnostics for Oncology Sales Volume Share by Player in 2021
Table Companion Diagnostics for Oncology Revenue (Million USD) by Player (2017-2022)
Table Companion Diagnostics for Oncology Revenue Market Share by Player (2017-2022)
Table Companion Diagnostics for Oncology Price by Player (2017-2022)
Table Companion Diagnostics for Oncology Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Companion Diagnostics for Oncology Sales Volume, Region Wise (2017-2022)
Table Global Companion Diagnostics for Oncology Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Companion Diagnostics for Oncology Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Companion Diagnostics for Oncology Sales Volume Market Share, Region Wise in 2021
Table Global Companion Diagnostics for Oncology Revenue (Million USD), Region Wise (2017-2022)
Table Global Companion Diagnostics for Oncology Revenue Market Share, Region Wise (2017-2022)
Figure Global Companion Diagnostics for Oncology Revenue Market Share, Region Wise (2017-2022)
Figure Global Companion Diagnostics for Oncology Revenue Market Share, Region Wise in 2021
Table Global Companion Diagnostics for Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Companion Diagnostics for Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Companion Diagnostics for Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Companion Diagnostics for Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Companion Diagnostics for Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Companion Diagnostics for Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Companion Diagnostics for Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Companion Diagnostics for Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Companion Diagnostics for Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Companion Diagnostics for Oncology Sales Volume by Type (2017-2022)
Table Global Companion Diagnostics for Oncology Sales Volume Market Share by Type (2017-2022)
Figure Global Companion Diagnostics for Oncology Sales Volume Market Share by Type in 2021
Table Global Companion Diagnostics for Oncology Revenue (Million USD) by Type (2017-2022)
Table Global Companion Diagnostics for Oncology Revenue Market Share by Type (2017-2022)
Figure Global Companion Diagnostics for Oncology Revenue Market Share by Type in 2021
Table Companion Diagnostics for Oncology Price by Type (2017-2022)
Figure Global Companion Diagnostics for Oncology Sales Volume and Growth Rate of Product (2017-2022)
Figure Global Companion Diagnostics for Oncology Revenue (Million USD) and Growth Rate of Product (2017-2022)
Figure Global Companion Diagnostics for Oncology Sales Volume and Growth Rate of Service (2017-2022)
Figure Global Companion Diagnostics for Oncology Revenue (Million USD) and Growth Rate of Service (2017-2022)
Table Global Companion Diagnostics for Oncology Consumption by Application (2017-2022)
Table Global Companion Diagnostics for Oncology Consumption Market Share by Application (2017-2022)
Table Global Companion Diagnostics for Oncology Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Companion Diagnostics for Oncology Consumption Revenue Market Share by Application (2017-2022)
Table Global Companion Diagnostics for Oncology Consumption and Growth Rate of Hospital (2017-2022)
Table Global Companion Diagnostics for Oncology Consumption and Growth Rate of Pathology/Diagnostic Laboratory (2017-2022)
Table Global Companion Diagnostics for Oncology Consumption and Growth Rate of Academic Medical Center (2017-2022)
Figure Global Companion Diagnostics for Oncology Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Companion Diagnostics for Oncology Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Companion Diagnostics for Oncology Price and Trend Forecast (2022-2027)
Figure USA Companion Diagnostics for Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Companion Diagnostics for Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Companion Diagnostics for Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Companion Diagnostics for Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Companion Diagnostics for Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Companion Diagnostics for Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Companion Diagnostics for Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Companion Diagnostics for Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Companion Diagnostics for Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Companion Diagnostics for Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Companion Diagnostics for Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Companion Diagnostics for Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Companion Diagnostics for Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Companion Diagnostics for Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Companion Diagnostics for Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Companion Diagnostics for Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Companion Diagnostics for Oncology Market Sales Volume Forecast, by Type
Table Global Companion Diagnostics for Oncology Sales Volume Market Share Forecast, by Type
Table Global Companion Diagnostics for Oncology Market Revenue (Million USD) Forecast, by Type
Table Global Companion Diagnostics for Oncology Revenue Market Share Forecast, by Type
Table Global Companion Diagnostics for Oncology Price Forecast, by Type
Figure Global Companion Diagnostics for Oncology Revenue (Million USD) and Growth Rate of Product (2022-2027)
Figure Global Companion Diagnostics for Oncology Revenue (Million USD) and Growth Rate of Product (2022-2027)
Figure Global Companion Diagnostics for Oncology Revenue (Million USD) and Growth Rate of Service (2022-2027)
Figure Global Companion Diagnostics for Oncology Revenue (Million USD) and Growth Rate of Service (2022-2027)
Table Global Companion Diagnostics for Oncology Market Consumption Forecast, by Application
Table Global Companion Diagnostics for Oncology Consumption Market Share Forecast, by Application
Table Global Companion Diagnostics for Oncology Market Revenue (Million USD) Forecast, by Application
Table Global Companion Diagnostics for Oncology Revenue Market Share Forecast, by Application
Figure Global Companion Diagnostics for Oncology Consumption Value (Million USD) and Growth Rate of Hospital (2022-2027)
Figure Global Companion Diagnostics for Oncology Consumption Value (Million USD) and Growth Rate of Pathology/Diagnostic Laboratory (2022-2027)
Figure Global Companion Diagnostics for Oncology Consumption Value (Million USD) and Growth Rate of Academic Medical Center (2022-2027)
Figure Companion Diagnostics for Oncology Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Abbott Profile
Table Abbott Companion Diagnostics for Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Abbott Companion Diagnostics for Oncology Sales Volume and Growth Rate
Figure Abbott Revenue (Million USD) Market Share 2017-2022
Table Invivoscribe, Inc. Profile
Table Invivoscribe, Inc. Companion Diagnostics for Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Invivoscribe, Inc. Companion Diagnostics for Oncology Sales Volume and Growth Rate
Figure Invivoscribe, Inc. Revenue (Million USD) Market Share 2017-2022
Table QIAGEN N.V. Profile
Table QIAGEN N.V. Companion Diagnostics for Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure QIAGEN N.V. Companion Diagnostics for Oncology Sales Volume and Growth Rate
Figure QIAGEN N.V. Revenue (Million USD) Market Share 2017-2022
Table Agilent Technologies, Inc. Profile
Table Agilent Technologies, Inc. Companion Diagnostics for Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Agilent Technologies, Inc. Companion Diagnostics for Oncology Sales Volume and Growth Rate
Figure Agilent Technologies, Inc. Revenue (Million USD) Market Share 2017-2022
Table bioMerieux SA Profile
Table bioMerieux SA Companion Diagnostics for Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure bioMerieux SA Companion Diagnostics for Oncology Sales Volume and Growth Rate
Figure bioMerieux SA Revenue (Million USD) Market Share 2017-2022
Table F. Hoffmann-La Roche Ltd. Profile
Table F. Hoffmann-La Roche Ltd. Companion Diagnostics for Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure F. Hoffmann-La Roche Ltd. Companion Diagnostics for Oncology Sales Volume and Growth Rate
Figure F. Hoffmann-La Roche Ltd. Revenue (Million USD) Market Share 2017-2022
Table Thermo Fisher Scientific, Inc. Profile
Table Thermo Fisher Scientific, Inc. Companion Diagnostics for Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Thermo Fisher Scientific, Inc. Companion Diagnostics for Oncology Sales Volume and Growth Rate
Figure Thermo Fisher Scientific, Inc. Revenue (Million USD) Market Share 2017-2022
Table ARUP Laboratories Profile
Table ARUP Laboratories Companion Diagnostics for Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure ARUP Laboratories Companion Diagnostics for Oncology Sales Volume and Growth Rate
Figure ARUP Laboratories Revenue (Million USD) Market Share 2017-2022
Table Myriad Genetics, Inc. Profile
Table Myriad Genetics, Inc. Companion Diagnostics for Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Myriad Genetics, Inc. Companion Diagnostics for Oncology Sales Volume and Growth Rate
Figure Myriad Genetics, Inc. Revenue (Million USD) Market Share 2017-2022
Table Illumina, Inc. Profile
Table Illumina, Inc. Companion Diagnostics for Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Illumina, Inc. Companion Diagnostics for Oncology Sales Volume and Growth Rate
Figure Illumina, Inc. Revenue (Million USD) Market Share 2017-2022
Figure Companion Diagnostics for Oncology Product Picture
Table Global Companion Diagnostics for Oncology Market Sales Volume and CAGR (%) Comparison by Type
Table Companion Diagnostics for Oncology Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Companion Diagnostics for Oncology Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Companion Diagnostics for Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Companion Diagnostics for Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Companion Diagnostics for Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Companion Diagnostics for Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Companion Diagnostics for Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Companion Diagnostics for Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Companion Diagnostics for Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Companion Diagnostics for Oncology Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Companion Diagnostics for Oncology Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Companion Diagnostics for Oncology Industry Development
Table Global Companion Diagnostics for Oncology Sales Volume by Player (2017-2022)
Table Global Companion Diagnostics for Oncology Sales Volume Share by Player (2017-2022)
Figure Global Companion Diagnostics for Oncology Sales Volume Share by Player in 2021
Table Companion Diagnostics for Oncology Revenue (Million USD) by Player (2017-2022)
Table Companion Diagnostics for Oncology Revenue Market Share by Player (2017-2022)
Table Companion Diagnostics for Oncology Price by Player (2017-2022)
Table Companion Diagnostics for Oncology Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Companion Diagnostics for Oncology Sales Volume, Region Wise (2017-2022)
Table Global Companion Diagnostics for Oncology Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Companion Diagnostics for Oncology Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Companion Diagnostics for Oncology Sales Volume Market Share, Region Wise in 2021
Table Global Companion Diagnostics for Oncology Revenue (Million USD), Region Wise (2017-2022)
Table Global Companion Diagnostics for Oncology Revenue Market Share, Region Wise (2017-2022)
Figure Global Companion Diagnostics for Oncology Revenue Market Share, Region Wise (2017-2022)
Figure Global Companion Diagnostics for Oncology Revenue Market Share, Region Wise in 2021
Table Global Companion Diagnostics for Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Companion Diagnostics for Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Companion Diagnostics for Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Companion Diagnostics for Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Companion Diagnostics for Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Companion Diagnostics for Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Companion Diagnostics for Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Companion Diagnostics for Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Companion Diagnostics for Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Companion Diagnostics for Oncology Sales Volume by Type (2017-2022)
Table Global Companion Diagnostics for Oncology Sales Volume Market Share by Type (2017-2022)
Figure Global Companion Diagnostics for Oncology Sales Volume Market Share by Type in 2021
Table Global Companion Diagnostics for Oncology Revenue (Million USD) by Type (2017-2022)
Table Global Companion Diagnostics for Oncology Revenue Market Share by Type (2017-2022)
Figure Global Companion Diagnostics for Oncology Revenue Market Share by Type in 2021
Table Companion Diagnostics for Oncology Price by Type (2017-2022)
Figure Global Companion Diagnostics for Oncology Sales Volume and Growth Rate of Product (2017-2022)
Figure Global Companion Diagnostics for Oncology Revenue (Million USD) and Growth Rate of Product (2017-2022)
Figure Global Companion Diagnostics for Oncology Sales Volume and Growth Rate of Service (2017-2022)
Figure Global Companion Diagnostics for Oncology Revenue (Million USD) and Growth Rate of Service (2017-2022)
Table Global Companion Diagnostics for Oncology Consumption by Application (2017-2022)
Table Global Companion Diagnostics for Oncology Consumption Market Share by Application (2017-2022)
Table Global Companion Diagnostics for Oncology Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Companion Diagnostics for Oncology Consumption Revenue Market Share by Application (2017-2022)
Table Global Companion Diagnostics for Oncology Consumption and Growth Rate of Hospital (2017-2022)
Table Global Companion Diagnostics for Oncology Consumption and Growth Rate of Pathology/Diagnostic Laboratory (2017-2022)
Table Global Companion Diagnostics for Oncology Consumption and Growth Rate of Academic Medical Center (2017-2022)
Figure Global Companion Diagnostics for Oncology Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Companion Diagnostics for Oncology Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Companion Diagnostics for Oncology Price and Trend Forecast (2022-2027)
Figure USA Companion Diagnostics for Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Companion Diagnostics for Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Companion Diagnostics for Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Companion Diagnostics for Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Companion Diagnostics for Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Companion Diagnostics for Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Companion Diagnostics for Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Companion Diagnostics for Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Companion Diagnostics for Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Companion Diagnostics for Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Companion Diagnostics for Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Companion Diagnostics for Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Companion Diagnostics for Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Companion Diagnostics for Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Companion Diagnostics for Oncology Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Companion Diagnostics for Oncology Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Companion Diagnostics for Oncology Market Sales Volume Forecast, by Type
Table Global Companion Diagnostics for Oncology Sales Volume Market Share Forecast, by Type
Table Global Companion Diagnostics for Oncology Market Revenue (Million USD) Forecast, by Type
Table Global Companion Diagnostics for Oncology Revenue Market Share Forecast, by Type
Table Global Companion Diagnostics for Oncology Price Forecast, by Type
Figure Global Companion Diagnostics for Oncology Revenue (Million USD) and Growth Rate of Product (2022-2027)
Figure Global Companion Diagnostics for Oncology Revenue (Million USD) and Growth Rate of Product (2022-2027)
Figure Global Companion Diagnostics for Oncology Revenue (Million USD) and Growth Rate of Service (2022-2027)
Figure Global Companion Diagnostics for Oncology Revenue (Million USD) and Growth Rate of Service (2022-2027)
Table Global Companion Diagnostics for Oncology Market Consumption Forecast, by Application
Table Global Companion Diagnostics for Oncology Consumption Market Share Forecast, by Application
Table Global Companion Diagnostics for Oncology Market Revenue (Million USD) Forecast, by Application
Table Global Companion Diagnostics for Oncology Revenue Market Share Forecast, by Application
Figure Global Companion Diagnostics for Oncology Consumption Value (Million USD) and Growth Rate of Hospital (2022-2027)
Figure Global Companion Diagnostics for Oncology Consumption Value (Million USD) and Growth Rate of Pathology/Diagnostic Laboratory (2022-2027)
Figure Global Companion Diagnostics for Oncology Consumption Value (Million USD) and Growth Rate of Academic Medical Center (2022-2027)
Figure Companion Diagnostics for Oncology Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Abbott Profile
Table Abbott Companion Diagnostics for Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Abbott Companion Diagnostics for Oncology Sales Volume and Growth Rate
Figure Abbott Revenue (Million USD) Market Share 2017-2022
Table Invivoscribe, Inc. Profile
Table Invivoscribe, Inc. Companion Diagnostics for Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Invivoscribe, Inc. Companion Diagnostics for Oncology Sales Volume and Growth Rate
Figure Invivoscribe, Inc. Revenue (Million USD) Market Share 2017-2022
Table QIAGEN N.V. Profile
Table QIAGEN N.V. Companion Diagnostics for Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure QIAGEN N.V. Companion Diagnostics for Oncology Sales Volume and Growth Rate
Figure QIAGEN N.V. Revenue (Million USD) Market Share 2017-2022
Table Agilent Technologies, Inc. Profile
Table Agilent Technologies, Inc. Companion Diagnostics for Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Agilent Technologies, Inc. Companion Diagnostics for Oncology Sales Volume and Growth Rate
Figure Agilent Technologies, Inc. Revenue (Million USD) Market Share 2017-2022
Table bioMerieux SA Profile
Table bioMerieux SA Companion Diagnostics for Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure bioMerieux SA Companion Diagnostics for Oncology Sales Volume and Growth Rate
Figure bioMerieux SA Revenue (Million USD) Market Share 2017-2022
Table F. Hoffmann-La Roche Ltd. Profile
Table F. Hoffmann-La Roche Ltd. Companion Diagnostics for Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure F. Hoffmann-La Roche Ltd. Companion Diagnostics for Oncology Sales Volume and Growth Rate
Figure F. Hoffmann-La Roche Ltd. Revenue (Million USD) Market Share 2017-2022
Table Thermo Fisher Scientific, Inc. Profile
Table Thermo Fisher Scientific, Inc. Companion Diagnostics for Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Thermo Fisher Scientific, Inc. Companion Diagnostics for Oncology Sales Volume and Growth Rate
Figure Thermo Fisher Scientific, Inc. Revenue (Million USD) Market Share 2017-2022
Table ARUP Laboratories Profile
Table ARUP Laboratories Companion Diagnostics for Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure ARUP Laboratories Companion Diagnostics for Oncology Sales Volume and Growth Rate
Figure ARUP Laboratories Revenue (Million USD) Market Share 2017-2022
Table Myriad Genetics, Inc. Profile
Table Myriad Genetics, Inc. Companion Diagnostics for Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Myriad Genetics, Inc. Companion Diagnostics for Oncology Sales Volume and Growth Rate
Figure Myriad Genetics, Inc. Revenue (Million USD) Market Share 2017-2022
Table Illumina, Inc. Profile
Table Illumina, Inc. Companion Diagnostics for Oncology Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Illumina, Inc. Companion Diagnostics for Oncology Sales Volume and Growth Rate
Figure Illumina, Inc. Revenue (Million USD) Market Share 2017-2022
